title: Resolution of metastatic bone lesions following combination therapy with active vitamin D3 analogue and interferon-alpha in a patient with renal cell carcinoma.
authors.affiliation: Department of Urology, Iwate Medical University School of Medicine, Morioka, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Fujioka
authors.forename: T
authors.initials: T
authors.lastname: Okamoto
authors.forename: Y
authors.initials: Y
authors.lastname: Suzuki
authors.forename: H
authors.initials: H
authors.lastname: Aoki
authors.forename: S
authors.initials: S
authors.lastname: Numasato
authors.forename: T
authors.initials: T
authors.lastname: Kubo
mesh_terms: D001859:Bone Neoplasms / Q000556:secondary / Q000628:therapy*; D002292:Carcinoma, Renal Cell / Q000556:secondary / Q000628:therapy*; D003131:Combined Modality Therapy; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use*; D016898:Interferon-alpha / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D012074:Remission Induction
chemical_list: D006887:Hydroxycholecalciferols; D016898:Interferon-alpha; C008088:alfacalcidol